Mohsen I. Mabudian, M.D.
NPI 1629022819ActiveIndividual· Allergy & Immunology· Redlands, CA
Allergy & Immunology (M.D.) in Redlands, California, licensed in CA, with an NPI issued in May 2006. In 2024 Medicare paid $4,495,687 for 281 patients, and Part D covered 428 of their prescriptions, 68% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 27 companies reporting payments in 2025, $6,487 in all, mostly food and beverage.
Overview
| NPI | 1629022819 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | May 20, 2006 |
| Last updated in NPPES | Jul 13, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology Primary | 207K00000X | C51804 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Allergy/Immunology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 281 |
|---|---|
| Services billed | 178,843 across 59 procedure codes |
| Paid by Medicare | $4,495,687 |
Part D prescriptions in 2024
| Prescriptions (claims) | 428 · 519 30-day fills |
|---|---|
| Patients | 63 |
| Total drug cost | $253,311 |
| Generic share | 68% of claims |
Education and affiliations
| Graduation year | 1997 |
|---|---|
| Medicare specialty | Allergy/Immunology |
| Telehealth | Offers telehealth |
Industry payments (Open Payments)
- 2025$6,487 · 228 payments from 27 companies
- 2024$2,531 · 119 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,554 | 62 |
| Genzyme Corporation | $855.05 | 27 |
| Abbvie Inc. | $481.39 | 7 |
| Regeneron Healthcare Solutions, Inc. | $452.61 | 10 |
| Glaxosmithkline, LLC. | $443.54 | 15 |
What the 2025 payments were for
- Food and Beverage$6,257 · 224 payments
- Education$230.42 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records